ABSTRACT
OBJECTIVE: To assess the predictive value of MRI vertebral end-plate changes (Modic) on clinical outcome of surgically treated lumbar single-level degenerative disc disease (DDD). METHODS: A cohort of 60 patients was included. Patient groups were similar in respect of age, gender and clinical presentation, allowing comparisons. Patient age ranged from 30 to 72 years (mean: 45.8 years). All patients suffered severe chronic low back pain for more than 6 months, with single-level symptomatic DDD. All patients experienced segmental instrumented interbody (n = 22) or posterolateral (n = 38) fusion. Clinical outcome was assessed by using a visual analog scale (VAS) and the functional disability scale of the Japanese Orthopaedic Association (JOA) for lumbar spine. The number of patients for each Modic group was as follows: Modic type 0, n = 15; Modic type I, n = 22; Modic type II, n = 14; and Modic type I/II, n = 9. Fusion rates were similar for each Modic group of patients. Mean follow-up was 14 months. RESULTS: The pre-operative mean VAS improved by 53.5% (from 8.2+/-2.0 to 3.8+/-1.9, p < 0.05) and the pre-operative mean JOA score by 58% (from 5.5+/-2.1 to 11.0+/-2.4, p < 0.05). Patients harboring Modic type I changes improved much better than others (p < 0.05). Conversely, clinical outcome of patients presenting with Modic type II lesions was poor. CONCLUSION: This study confirms instrumented fusion as an effective treatment in symptomatic lumbar DDD. Preoperative combination of low back pain of discal origin and severe DDD with Modic type I lesion on MRI may lead to excellent results after fusion in a large proportion of patients. Conversely, arthrodesis for patients harboring Modic type II abnormalities implicates smaller benefit of doubtful clinical significance.
Subject(s)
Lumbar Vertebrae , Magnetic Resonance Imaging , Spinal Diseases/pathology , Spinal Diseases/surgery , Adult , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Treatment OutcomeABSTRACT
OBJECTIVE: To compare the outcome between operated and non-operated brainstem cavernomas. METHOD: Clinical and radiological data of 30 patients harboring 35 brainstem cavernomas were retrospectively reviewed. The mean follow-up period was 47 months. Relationship between the cavernoma and the pi maer was graded. The histology of each operative case was systematically confirmed. The Karnofsky mean score was calculated at admission and at the end of the follow-up period. Patients were classified in three groups according to their outcome grade (Group I=good; Group II=unchanged; Group III=worse). We compared the outcome between operated and non-operated patients. For operated cases, we found several factors of poor outcome. Statistical tests used to compare the groups of patients were Yates modified chi(2) with calculation of the exact probability. Chosen risk was 5%. RESULTS: Thirty-eight percent of operated patients were permanently disabled after surgery whereas the same proportion was improved. None of the patients in the control group worsened at the mean 47-month follow-up despite the occurrence of two hemorrhagic events. Statistical study showed that treatment modality affected clinical outcome in these patients. Only patients presenting with multiple deficits and progressive neurological deterioration were improved with surgery. Surgical access through the floor of the fourth ventricle was correlated with a poor outcome. Partial removal of the cavernoma increased the risk of future hemorrhage. CONCLUSION: Surgery showed no proof of its efficiency in the management of brainstem cavernomas at the end of the follow-up period. Indications of surgical treatment must be restricted to cases with a severe and progressive neurological deterioration.